University of New Mexi
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of New Mexi sits in the top decile of US sponsors by registered trial count (#286 of 15,742 sponsors by registered trial count).
University of New Mexi: 76 sponsored US clinical trials, 23 recruiting.
University of New Mexi sponsors 76 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 42 completed. 3 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Pain, with 6 trials.
Top-decile sponsor footprint
University of New Mexi ranks in the top decile of sponsors by registered trial count (#286 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
42 of 42 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
76 total, page 2 of 2
Tranexamic Acid and Blood Clots in Knee Surgery
NCT02867163
Urease Breath Test for Rapid Characterization of Pneumonia
NCT03100760
mTORC1 and Autophagy in Human Brown Adipocytes
NCT04206124
Travelling for Rights
NCT03258463
Music Therapy in Procedural Sedation in the Emergency Department
NCT02676206
Fluid Chloride and AKI in Cardiopulmonary Bypass
NCT02668952
Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence
NCT03037749
Perineorrhaphy Outcomes Related to Body Imagery
NCT02548858
Apneic Oxygenation During Airway Management in Pediatric Patients
NCT02437864
Pilot Study of Combined Treatment for Veterans With Chronic Pain & Opiate Misuse
NCT02423772
Family Listening Program: Multi-Tribal Implementation and Evaluation
NCT03142009
Nitrous Oxide for Pain Management During In-office Transcervical Sterilization
NCT02312739
Effectiveness of Peer-Delivered Trauma-Specific Treatment
NCT02081417
Iwankapiya-Healing: Historical Trauma Practice and Group IPT for American Indians
NCT02124694
Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments
NCT01207791
Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia
NCT01169909
Effect of Combined Exercise, Heat, and Quercetin Supplementation on Whole Body Stress Response
NCT01168739
Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes
NCT00659165
Acupuncture for Anxiety in Women With Breast Cancer: A Feasibility Study
NCT00322504
A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients
NCT00690521
Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
NCT00249977
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
NCT00276003
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
NCT00250783
Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women
NCT00375297
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
NCT00250796
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
NCT00251797
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 9 |
| Phase 2 | 5 |
| Phase 4 | 3 |
Therapeutic Areas
What is open in the University of New Mexi pipeline
23 recruiting of 76 indexed (30% open); 42 completed (55%).
Phase mix: 3 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Chronic Pain (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of New Mexi: open-pipeline peers nationwide
Peers matched on 76 registered trials and 30% open enrollment, not the therapeutic-area sidebar.
University of New Mexi sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 76 trials (± recruiting share)
- Ionis Pharmaceuticals · 76 trials · 12% recruiting
- MetroHealth Medical Center · 76 trials · 13% recruiting
- Texas Tech University Health Sciences Center · 76 trials · 13% recruiting
- University of Hawaii · 77 trials · 17% recruiting
Sponsors near 30% open enrollment (± trial volume)
- Tulane University · 30% recruiting · 73 trials
- New York University · 30% recruiting · 83 trials
- Adverum Biotechnologies · 30% recruiting · 10 trials
- Centre hospitalier de l'Université de Montréal (CHUM) · 30% recruiting · 10 trials
Related
What to do with this University of New Mexi page
76 registered trials is a research-attention snapshot, not an endorsement of University of New Mexi or any single study.
- 23 of University of New Mexi's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Pain is the condition University of New Mexi studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of New Mexi pipeline card: 76 registered trials from official public datasets.Report a data error.